PT Ekadharma International Tbk (IDX:EKAD)
Indonesia · Delayed Price · Currency is IDR 180.00
-1.00 (-0.55%)
Apr 2, 2026, 4:10 PM WIB
IDX:EKAD Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 529,530 | 530,432 | 518,359 | 614,477 | 629,879 | |
Revenue Growth (YoY) | -0.17% | 2.33% | -15.64% | -2.44% | -6.20% |
Cost of Revenue | 374,597 | 366,677 | 346,093 | 424,915 | 406,365 |
Gross Profit | 154,933 | 163,755 | 172,266 | 189,562 | 223,514 |
Selling, General & Admin | 104,762 | 100,212 | 97,439 | 100,475 | 99,953 |
Other Operating Expenses | 3,287 | -602.63 | -346.96 | -2,102 | -6,561 |
Operating Expenses | 108,049 | 99,610 | 97,092 | 98,374 | 93,391 |
Operating Income | 46,884 | 64,145 | 75,174 | 91,188 | 130,123 |
Interest Expense | -1,735 | -1,789 | -1,961 | -1,908 | -2,410 |
Interest & Investment Income | - | 18,801 | 12,087 | 7,269 | 8,282 |
Earnings From Equity Investments | -20.62 | -47.19 | 94.29 | 113.67 | 22.87 |
Currency Exchange Gain (Loss) | - | -2,974 | 1,895 | - | 1,807 |
Other Non Operating Income (Expenses) | 16,650 | -39.92 | -35.86 | -72.39 | -207.3 |
EBT Excluding Unusual Items | 61,779 | 78,096 | 87,254 | 96,591 | 137,617 |
Gain (Loss) on Sale of Investments | - | 3,064 | - | 420.32 | - |
Gain (Loss) on Sale of Assets | - | 458.56 | 118.35 | 900.08 | 103.43 |
Pretax Income | 61,779 | 81,619 | 87,372 | 97,911 | 137,720 |
Income Tax Expense | 9,953 | 17,063 | 13,305 | 19,832 | 29,230 |
Earnings From Continuing Operations | 51,826 | 64,556 | 74,067 | 78,080 | 108,490 |
Minority Interest in Earnings | 1,199 | -120.89 | -2,122 | -1,359 | -4,081 |
Net Income | 53,025 | 64,435 | 71,944 | 76,721 | 104,410 |
Net Income to Common | 53,025 | 64,435 | 71,944 | 76,721 | 104,410 |
Net Income Growth | -17.71% | -10.44% | -6.23% | -26.52% | 11.67% |
Shares Outstanding (Basic) | 3,493 | 3,494 | 3,494 | 3,494 | 3,494 |
Shares Outstanding (Diluted) | 3,493 | 3,494 | 3,494 | 3,494 | 3,494 |
Shares Change (YoY) | -0.02% | - | - | - | - |
EPS (Basic) | 15.18 | 18.44 | 20.59 | 21.96 | 29.88 |
EPS (Diluted) | 15.18 | 18.44 | 20.59 | 21.96 | 29.88 |
EPS Growth | -17.69% | -10.44% | -6.23% | -26.52% | 11.67% |
Free Cash Flow | 83,103 | 37,511 | 75,148 | 87,080 | 33,936 |
Free Cash Flow Per Share | 23.79 | 10.74 | 21.51 | 24.92 | 9.71 |
Dividend Per Share | - | 9.000 | 9.000 | 9.000 | 10.000 |
Dividend Growth | - | - | - | -10.00% | 11.11% |
Gross Margin | 29.26% | 30.87% | 33.23% | 30.85% | 35.48% |
Operating Margin | 8.85% | 12.09% | 14.50% | 14.84% | 20.66% |
Profit Margin | 10.01% | 12.15% | 13.88% | 12.49% | 16.58% |
Free Cash Flow Margin | 15.69% | 7.07% | 14.50% | 14.17% | 5.39% |
EBITDA | 58,435 | 81,188 | 92,520 | 108,215 | 150,027 |
EBITDA Margin | 11.04% | 15.31% | 17.85% | 17.61% | 23.82% |
D&A For EBITDA | 11,551 | 17,044 | 17,345 | 17,027 | 19,904 |
EBIT | 46,884 | 64,145 | 75,174 | 91,188 | 130,123 |
EBIT Margin | 8.85% | 12.09% | 14.50% | 14.84% | 20.66% |
Effective Tax Rate | 16.11% | 20.91% | 15.23% | 20.26% | 21.22% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.